Research Reports
Non-invasive Prenatal Testing (NIPT) Market – High awareness regarding benefits of non-invasive testing methods is expected to boost the growth of the market Non-invasive Prenatal Testing (NIPT) Market – High awareness regarding benefits of non-invasive testing methods is expected to boost the growth of the market Published by Coherent Market Insights
Posted on September 28, 2021
Non-invasive prenatal testing (NIPT) is a DNA test on maternal blood to screen pregnancies for the most common fetal chromosome anomalies such as trisomy 21 that is Down syndrome, trisomy 18 Edwards syndrome and trisomy 13 Patau syndrome. During non-invasive prenatal testing DNA from the mother and fetus is extracted from maternal blood sample and it is recommended for women who have risk factors for having a baby who has a chromosomal condition. Increasing launches and approvals of new non-invasive prenatal tests (NIPT) along with increasing prevalence of chromosomal disorders is expected to propel the market growth during the forecasted period.
Key Players Profiled in the Non-invasive Prenatal Testing (NIPT) Market Report are as follows: Ariosa Diagnostics, Inc., BGI Diagnosis Co., Ltd., Berry Genomics Corporation, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom, Inc., Natera, Inc., Axia Women’s Health, Eluthia, BillionToOne, Inc., and Quest Diagnostics Incorporated.
Request Sample Copy of Non-invasive Prenatal Testing (NIPT) Report @ https://www.coherentmarketinsights.com/insight/request-sample/579
The global non-invasive prenatal testing market was valued at US$ 882.9 Mn in 2019 and is forecast to reach a value of US$ 1,936.4 Mn by 2027 at a CAGR of 10.3% between 2020 and 2027 .
High prevalence of chromosomal disorders is expected to propel growth of the global non-invasive prenatal testing market over the forecast period. For instance, according to the study, ‘Estimating Nationwide Prevalence of Live Births with Down Syndrome and Their Medical Expenditures in Korea’, published in Journal of Korean Medical Science in August 2019, the prevalence of live births with Down’s syndrome was 5.03 per 10,000 births between 2007 and 2016.
Moreover, high awareness regarding benefits of non-invasive testing methods is also expected to aid in growth of the global non-invasive prenatal testing market. Obstetricians are increasingly recommending patients to undergo non-invasive tests as an alternative to invasive methods and initial diagnostic screening in the first trimester of a pregnancy.
Enquiry Before Buying This Report: https://www.coherentmarketinsights.com/insight/talk-to-analyst/579
Table of Contents
Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Test Type
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions
COVID19 Impact on the market
Global Non-Invasive Prenatal Testing Market, By Test Type, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Panel 1 Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Panel 2 Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Panel 3 Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Global Non-Invasive Prenatal Testing Market, By End User, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Maternity Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Global Non-Invasive Prenatal Testing Market, By Region, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2020 and 2027 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Latin America
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Germany
U.K.
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
North Africa
Central Africa
South Africa
Competitive Landscape
Company Profiles
Ariosa Diagnostics, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
BGI Diagnosis Co., Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Berry Genomics Corporation
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Illumina, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
LifeCodexx AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Natera, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sequenom, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Natera, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Axia Women’s Health
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Eluthia
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
BillionToOne, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Quest Diagnostics Incorporated
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Section
References
Research Methodology
About us and Sales Contact
Why You Should Buy This Report?
• To gain an in-depth understanding of Non-invasive Prenatal Testing (NIPT) market globally
• To identify the on-going trends and anticipated growth in the next nine years
• To help industry consultants, Non-invasive Prenatal Testing (NIPT) market other stakeholders align their market-centric strategies
• To obtain research-based business decisions and add weight to presentations and marketing strategies
• To gain competitive knowledge of leading market players
Request for Customization: https://www.coherentmarketinsights.com/insight/request-customization/579
The report answers questions such as:
• What is the market size and forecast of the Non-invasive Prenatal Testing (NIPT) market?
• What are the inhibiting factors and impact of COVID-19 shaping the Non-invasive Prenatal Testing (NIPT) market during the forecast period?
• Which are the products/segments/applications/areas to invest in over the forecast period in the Non-invasive Prenatal Testing (NIPT) market?
• What is the competitive strategic window for opportunities in the Non-invasive Prenatal Testing (NIPT) market?
• What are the technology trends and regulatory frameworks in the Non-invasive Prenatal Testing (NIPT) market?
• What are the modes and strategic moves considered suitable for entering the Non-invasive Prenatal Testing (NIPT) market?
Note: Access insightful study with over 1 50 + pages, list of tables & figures, profiling 20 + companies.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact us:
Mr. Shahwww.coherentmarketinsights.com
The post Non-invasive Prenatal Testing (NIPT) Market – High awareness regarding benefits of non-invasive testing methods is expected to boost the growth of the market appeared first on Gatorledger .
Non-invasive prenatal testing (NIPT) is a DNA test on maternal blood to screen pregnancies for the most common fetal chromosome anomalies such as trisomy 21 that is Down syndrome, trisomy 18 Edwards syndrome and trisomy 13 Patau syndrome. During non-invasive prenatal testing DNA from the mother and fetus is extracted from maternal blood sample and it is recommended for women who have risk factors for having a baby who has a chromosomal condition. Increasing launches and approvals of new non-invasive prenatal tests (NIPT) along with increasing prevalence of chromosomal disorders is expected to propel the market growth during the forecasted period.
Key Players Profiled in the Non-invasive Prenatal Testing (NIPT) Market Report are as follows: Ariosa Diagnostics, Inc., BGI Diagnosis Co., Ltd., Berry Genomics Corporation, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom, Inc., Natera, Inc., Axia Women’s Health, Eluthia, BillionToOne, Inc., and Quest Diagnostics Incorporated.
Request Sample Copy of Non-invasive Prenatal Testing (NIPT) Report @ https://www.coherentmarketinsights.com/insight/request-sample/579
The global non-invasive prenatal testing market was valued at US$ 882.9 Mn in 2019 and is forecast to reach a value of US$ 1,936.4 Mn by 2027 at a CAGR of 10.3% between 2020 and 2027 .
High prevalence of chromosomal disorders is expected to propel growth of the global non-invasive prenatal testing market over the forecast period. For instance, according to the study, ‘Estimating Nationwide Prevalence of Live Births with Down Syndrome and Their Medical Expenditures in Korea’, published in Journal of Korean Medical Science in August 2019, the prevalence of live births with Down’s syndrome was 5.03 per 10,000 births between 2007 and 2016.
Moreover, high awareness regarding benefits of non-invasive testing methods is also expected to aid in growth of the global non-invasive prenatal testing market. Obstetricians are increasingly recommending patients to undergo non-invasive tests as an alternative to invasive methods and initial diagnostic screening in the first trimester of a pregnancy.
Enquiry Before Buying This Report: https://www.coherentmarketinsights.com/insight/talk-to-analyst/579
Table of Contents Research Objectives and Assumptions Research Objectives Assumptions Abbreviations Market Purview Report DescriptionMarket Definition and Scope Executive SummaryMarket Snippet, By Test Type Market Snippet, By End User Market Snippet, By Region Coherent Opportunity Map (COM) Market Dynamics, Regulations, and Trends Analysis Market DynamicsDrivers Restraints Market Opportunities Impact Analysis Key Highlights Product launch PEST Analysis Technological Advancements Regulatory Scenario Mergers and Acquisitions COVID19 Impact on the market Global Non-Invasive Prenatal Testing Market, By Test Type, 2016 – 2027, (US$ Mn) IntroductionMarket Share Analysis, 2020 and 2027 (%) Y-o-Y Growth Analysis, 2017 – 2027 Segment Trends Panel 1 TestIntroduction Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn) Panel 2 TestIntroduction Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn) Panel 3 TestIntroduction Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn) Global Non-Invasive Prenatal Testing Market, By End User, 2016 – 2027, (US$ Mn) IntroductionMarket Share Analysis, 2020 and 2027 (%) Y-o-Y Growth Analysis, 2017 – 2027 Segment Trends HospitalsIntroduction Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn) Diagnostic LaboratoriesIntroduction Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn) Maternity CentersIntroduction Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn) Global Non-Invasive Prenatal Testing Market, By Region, 2016 – 2027, (US$ Mn) IntroductionMarket Share Analysis, By Region, 2020 and 2027 (%) Y-o-Y Growth Analysis, For Regions, 2017–2026 North AmericaMarket Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn) Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn) Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn) Latin AmericaMarket Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn) Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn) Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)Brazil Mexico Argentina Rest of Latin America EuropeMarket Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn) Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn) Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)Germany U.K. France Spain Italy Russia Rest of Europe Asia PacificMarket Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn) Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn) Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)China Japan India Australia South Korea ASEAN Rest of Asia Pacific Middle EastMarket Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn) Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn) Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)GCC Countries Israel Rest of Middle East AfricaMarket Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn) Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn) Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)North Africa Central Africa South Africa Competitive Landscape Company ProfilesAriosa Diagnostics, Inc.Company Overview Product Portfolio Financial Overview Key Highlights Market Strategies BGI Diagnosis Co., Ltd.Company Overview Product Portfolio Financial Overview Key Highlights Market Strategies Berry Genomics CorporationCompany Overview Product Portfolio Financial Overview Key Highlights Market Strategies Illumina, Inc.Company Overview Product Portfolio Financial Overview Key Highlights Market Strategies LifeCodexx AGCompany Overview Product Portfolio Financial Overview Key Highlights Market Strategies Natera, Inc.Company Overview Product Portfolio Financial Overview Key Highlights Market Strategies Sequenom, Inc.Company Overview Product Portfolio Financial Overview Key Highlights Market Strategies Natera, Inc.Company Overview Product Portfolio Financial Overview Key Highlights Market Strategies Axia Women’s HealthCompany Overview Product Portfolio Financial Overview Key Highlights Market Strategies EluthiaCompany Overview Product Portfolio Financial Overview Key Highlights Market Strategies BillionToOne, Inc.Company Overview Product Portfolio Financial Overview Key Highlights Market Strategies Quest Diagnostics IncorporatedCompany Overview Product Portfolio Financial Overview Key Highlights Market Strategies Section References Research Methodology About us and Sales Contact Why You Should Buy This Report?
• To gain an in-depth understanding of Non-invasive Prenatal Testing (NIPT) market globally
• To identify the on-going trends and anticipated growth in the next nine years
• To help industry consultants, Non-invasive Prenatal Testing (NIPT) market other stakeholders align their market-centric strategies
• To obtain research-based business decisions and add weight to presentations and marketing strategies
• To gain competitive knowledge of leading market players
Request for Customization: https://www.coherentmarketinsights.com/insight/request-customization/579
The report answers questions such as:
• What is the market size and forecast of the Non-invasive Prenatal Testing (NIPT) market?
• What are the inhibiting factors and impact of COVID-19 shaping the Non-invasive Prenatal Testing (NIPT) market during the forecast period?
• Which are the products/segments/applications/areas to invest in over the forecast period in the Non-invasive Prenatal Testing (NIPT) market?
• What is the competitive strategic window for opportunities in the Non-invasive Prenatal Testing (NIPT) market?
• What are the technology trends and regulatory frameworks in the Non-invasive Prenatal Testing (NIPT) market?
• What are the modes and strategic moves considered suitable for entering the Non-invasive Prenatal Testing (NIPT) market?
Note: Access insightful study with over 1 50 + pages, list of tables & figures, profiling 20 + companies.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact us:
Mr. Shahwww.coherentmarketinsights.com
The post Non-invasive Prenatal Testing (NIPT) Market – High awareness regarding benefits of non-invasive testing methods is expected to boost the growth of the market appeared first on Gatorledger .
